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Abstract 
 
Milk is a complex liquid that has expanded its more conventional role and is 
more than a source of nutrients for young mammals. In the last few decades, 
a great deal of research has shown that milk and dairy products provide a 
broad range of bioactive components. Bioactive components can be defined 
as components in foods that have a physiological function. The aim of this 
study was to give a general overview on bioactive components found in 
milk and dairy products and what valuable health effects they might have. 
Milk consists of a mixture of components but the main components are wa-
ter, lactose, fat, proteins and minerals. The composition of milk can differ 
and are influenced by number of dissimilar factors. In this thesis calcium, 
specific bioactive proteins (lactorferrin, α-lactalalbumin, β-lactoglobulin, 
glycomacropeptide, and immunoglobulin) oligosaccharides and conjugated 
linoleic acid will be overviewed. However, these components are just a 
small fraction of all bioactive components found in milk and dairy products.  
Some of them are natural milk components, others emerge during digestive 
processes or fermentation processes in dairy products. Numerous of health 
effects of these bioactive components have been described in in vitro stud-
ies, animal trials, a small number of epidemiological studies and human 
clinical trials. The studies show that these bioactive components exhibit 
antimicrobial effect, anticarcinogenic properties, ACE-inhibitory activity, 
anti-hypertension properties, effects on the cholesterol levels etc. Although 
bioactive components in milk and dairy products is a well studied area there 
is a lack of human clinical trials and epidemiological studies to draw con-
clusions regarding  health benefits in humans. However, the development of 
functional foods with health properties is a market that is expanding and 
will continue to do so in the coming future. Through the knowledge and 
understanding of how these components function, new health promoted 
products can be developed. 
  
 
Keywords: bioactive components, milk, dairy products, health effects  
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Sammanfattning 
 
Mjölk är en komplex vätska som är mycket mer än bara en källa av närings-
ämnen för unga däggdjur. Under de senaste decennierna har en hel del 
forskning demonstrerat att mjölk och mejeriprodukter innehåller ett brett 
spektrum av olika bioaktiva komponenter. Syftet med denna studie var att 
ge en litteraturöversikt över bioaktiva komponenter som finns i mjölk och 
mejeriprodukter och vilka fördelaktiga hälsoeffekter som de kan ha. Mjölk 
består av en blandning av olika komponenter men de huvudkomponenterna 
är vatten, laktos, fett, proteiner och mineraler. Mjölkens sammansättning 
kan dock variera och påverkas av olika möjliga faktorer. I den här litteratur-
studien kommer kalcium, specifika bioaktiva proteiner (laktoferrin, α-
lactalalbumin, β-laktoglobulin, glykomakropeptid, immunglobulin), oligo-
sackarider och konjugerad linolsyra att tas upp. Dessa komponenter är dock 
bara en liten del av alla bioaktiva komponenter som finns i mjölk och meje-
jeriprodukter. En del av dessa är naturliga mjölkkomponenter medan andra 
uppkommer under matsmältningsprocessen eller genom fermentation i me-
jeriprodukter. Många av hälsoeffekterna av dessa bioaktiva komponenter 
har beskrivits genomgående i in vitro studier, djurförsök och ett fåtal i epi-
demiologiska studier och kliniska prövningar. Studierna visade att dessa 
bioaktiva komponenter uppvisar antimikrobiell effekt, anticarcinogena 
egenskaper, ACE-hämmande aktivitet, anti-hypertoniska egenskaper, på-
verkan på kolesterolvärdet etc. Även om bioaktiva komponenter i mjölk och 
mejeriprodukter är ett välstuderat område är det brist på kliniska prövningar 
och epidemiologiska studier för att dra slutsatser angående hälsofördelar hos 
människan. Utvecklingen av funktionella livsmedel är en marknad som 
växer och kommer att fortsätta att göra det under den kommande framtiden. 
Genom kunskap och förståelse för hur dessa bioaktiva komponenter funge-
rar kan nya hälsoförebyggande produkter utvecklas.  
 
 
 
 
Nyckelord: Bioaktiva komponenter, mjölk, mejeriprodukter, hälsoeffekter 
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ACE Angiotensin-converting-
enzyme 
CLA Conjugated linoleic acid 
CVD Cardiovascular disease 
GMP Glycomacropeptide 
Ig Immunoglobulin 
α-La α-Lactalbumin 
LF Lactoferrin 
β-Lg β-Lactoglobulin 
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1 Introduction 
Milk is a complex liquid and one of nature's most complete food (Park, 2009). The 
main role of milk  is to fulfill the nutritional need for the neonate of the mammali-
an species during the first phase of  its life (Raikos & Dassios, 2013). The conven-
tional role of milk as nutrition for infants has expanded with time. Milk does not 
only provide growth to children but also nourishment for adults. However, aside 
from the nutritional values of milk, milk and dairy product have also become 
known to provide bioactive components. Many valuable constituents in milk have 
diverse but yet significant roles. Bioactive components could be defined as com-
pounds in foods that may exert physiological activity. Bioactive components of 
food origin could be provided to humans by intake of conventional food, function-
al foods or dietary supplement (Gobbetti & Minervini, 2007). Extensive research 
reports different advantageous health effects from bioactive components in milk 
and dairy products. The interest of bioactive components in milk and dairy prod-
ucts is greater than ever in today's society. As research into the health profits of 
food components have expanded, both food manufacturers and consumers have 
developed a greater understanding of the relationship between foodstuff and hu-
man health. With this knowledge of how bioactive components function, new 
treatments, drugs or food can be developed in the near future (Park, 2009).  
 
1.1 Aim 
The aim of this thesis was to provide a literature overview on bioactive compo-
nents in milk and dairy products and their beneficial effects on health.  
 
1.2 Demarcation 
This thesis will include studies made on milk from different species (human, bo-
vine, ovine, caprine, and goat). In addition, the studies in this literature study will 
include various types of study designs e.g. animal studies, in vitro studies, epide-
miological studies and clinical studies. 
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2 The composition of milk 
Milk is the primary source of nutrients for infants of mammals and is defined as 
the secretion from mammary glands of mammals. Milk consists of a complex mix-
ture of components. The major components are lactose, lipids, protein, minerals 
and water. The composition of milk varies and is reliant on which mammal, breed 
and even the individual animal. Moreover the stage of lactation and the feed could 
have a significant impact of the milk composition (Walstra et al., 2005).  
 
2.1 Lactose 
The major carbohydrate in milk is lactose or β-D-galactopyranosyl-(1,4)-D-
glucopyranose. Lactose is a disaccharide composed of D-galactose and D-glucose. 
Lactose mainly provides the infant mammal energy but also have other functions 
such as giving milk the sweet flavor. For the blood to be able to take up lactose it 
must first be hydrolyzed by the enzyme lactase to glucose and galactose. Individu-
als who metabolize lactose poorly due to a significant reduction in lactase activity 
are called lactose mal-absorbers. This condition can eventually lead to lactose 
intolerance (Walstra et al., 2005). 
 
2.2 Lipids 
The term lipid refers to all components soluble in non-polar organic solvents - 
phytosterols, tocopherols, free fatty acid etc. The term fat can sometimes be mixed 
up with lipids though fat refers to the mixture of triglycerides that are solidified at 
room temperature. The word fat will sometimes be used in this context since lipids 
is such an extensive term (Walstra et al., 2005). The majority of the lipids in milk 
occur as fat globules. Milk contains approximately 3- 5 % lipids, a value that var-
ies, and milk fat is emulsified in the aqueous water phase (Jensen, 2002). Milk fat 
mainly consists of triglycerides (TAG) which make up approximately 98 % of the 
milk fat. The rest is free fatty acid, cholesterol, diglycerides, monoglycerides and 
phospholipids. An exceedingly vital factor on determining the lipid properties is 
the pattern for the fatty acid, for instance the chemical reactivity and melting 
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range. The fatty acid composition varies depending on the degree of unsaturation, 
chain length and position of the double bond (Walstra et al., 2005).  
 
2.3 Proteins 
The primary function of protein in milk is to provide amino acids and nitrogen 
to young infants but milk proteins are also an essential part of the dietary proteins 
in adult humans (Nagpal et al., 2011). The two major fractions of proteins in milk 
are casein and whey protein. 
  Casein is the primary protein of these two and compromising ca 80 % of the 
milk protein. Casein micelles are formed through interaction between various ca-
sein proteins and calcium phosphate. This large colloidal complex particle has a 
spherical structure. Casein can further be divided into αs1-, αs2,-, β-, and -κ-
fractions (Chandan, 2007). Caseins are phosphoproteins that enclose phosphate 
groups esterified to the amino acid serine. The αs- and β-casein are more hydro-
phobic and are largely present in the interior of the micelles while κ-casein is pri-
marily found on the surface of the micelles. κ-Casein provides stability for the 
micelles in milk during the standard handling conditions. This is caused by the 
hydration of the κ-casein and the negative charge together with the fact that the 
hydrophilic fragment has a tendency to stick out from the micelle surface. It gives 
a hair-like structure and grants a spatial stability for the micelles. When manufac-
turing cheese, casein micelles coagulate by adding the enzyme complex rennet to 
the milk. A protease cleaves a definite bond in κ-casein and will make the hair-like 
structure detach from the micelle, making the surface uncharged and unstable.  
The micelles therefore aggregate and form a gel and can further be separated from 
the whey in the process of making cheese (Christian, 2008). 
 The other major protein fraction is whey, also called milk serum representing 
20 % of the milk proteins (Ko, 2009). This fraction includes β-lactoglobulin, α-
lactalbumin, lactoferrin, immunoglobulines, bovine serum albumin and various of 
enzymes. The spherical structures of whey proteins are much more in an ordered 
form than casein proteins. Whey proteins have disulfide linkages and are precipi-
tated under heat circumstances rather under acid conditions (Chandan, 2007). 
 Varieties of proteins and peptides derived from milk proteins have bioactive 
function and growing evidence on beneficial health effects has been put forward.  
 
 
2.4 Vitamins and minerals 
 
Milk contains both fat-soluble and some water soluble vitamins. Vitamin A can 
naturally be found in the fat component of whole milk (Chandan, 2007). It is not 
unusual to fortify milk with vitamin A prior to sale since  the separation process of 
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milk leads to small amounts of vitamin A in the low fat milk fraction (Christian, 
2008). Vitamin D is also naturally present in whole milk though in small amounts 
and therefore it is commonly fortified as well (Chandan, 2007).  
Calcium and phosphorus are the main minerals present in milk. Calcium can be 
found combined with the protein casein as calcium caseinate, with phosphorus as 
calcium phosphate and as calcium citrate. Furthermore, magnesium, potassium, 
sodium and sulfur is other minerals present in milk (Christian, 2008).  
9 
 
3 Twenty first century diseases 
 
3.1 Cardiovascular disease 
Cardiovascular disease (CVD) is the foremost cause of mortality globally, to-
day. More people die annually from CVD than from any other diseases or causes. 
CVDs include a group of disorders of heart and blood vessels such as, coronary 
heart disease, cerebrovascular disease etc. CVD can be developed from the pres-
ence of one or more risk factors such as diabetes, hypertension and hyperlipidem-
ia. These factors can be prevented by addressing a healthy diet, physical activity 
and nonusage of tobacco.  
 
3.1.1 Hypertension and antihypertensive activity 
 
Hypertension, also known as high blood pressure, is defined as systolic blood  
pressure above 140 mm Hg and/or a diastolic blood pressure over 90 mg Hg. The 
development of hypertension is a serious health condition and associated with 
CVD. Furthermore, it could influence other outcomes e.g. heart attack, stroke or 
heart failure (WHO, 2015).  
Angiotensin- converting enzyme (ACE) is an enzyme with multiple functions 
and is an essential component of the renin-angiostin-system. ACE can act as one 
of the major regulators of blood pressure by converting the enzyme angiotensin I 
to angiotensin II. Angiotensin II is thereby the hormone that increase the blood 
pressure by contracting the blood vessels (Nagpal et al., 2011). To prevent this, 
patients suffering from hypertension use ACE-inhibitors. This could be in form of 
pharmaceutical drugs. However, over the past decades numerous studies have 
demonstrated that bioactive peptides derived from milk protein have ACE-
inhibitory activity.  
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3.2 Osteoporosis 
Osteoporosis is a well-defined disease and is a condition of skeletal fragility. 
The condition is characterized by low bone mass and micro-architectural weaken-
ing of bone tissue which consequently increase the risk of fractures (Heaney, 
2000). Calcium has a significant role in a wide range of biological functions. One 
of the most important roles is to mineralize the skeleton. Lack of calcium can 
eventually contribute to osteoporosis. Since calcium cannot be produced of the 
body itself, it needs to be supplied through dietary intake (Peacock, 2010). Milk 
and dairy products are rich in calcium and hence major contributors of the mineral. 
Nutrition plays an essential role to maintain and develop the bone mass, although 
there are other aspects that could influence the development of osteoporosis addi-
tionally (Heaney, 2000). 
 
3.3 Cancer 
The second leading cause of mortality worldwide is cancer. The term cancer is 
somewhat broad and includes a large group of diseases that could affect any part 
of the body. A general defining aspect of cancer is the rapid formation of abnormal 
cells that grow beyond their common limitations. These abnormal cells can invade 
and spread to other organs, so called metastases. The metastases are the foremost 
cause of death from cancer. In spite the major advances that have been achieved in 
this field, the incidence of cancer is expected to continue rising the coming years. 
It is estimated to rise up to 70 % over the next 2 decades (WHO, 2015). 
Considerable amounts of studies have investigated the relation between diet and 
cancer prevention of different food constituents. During the past years, peptides 
derived from food components have proven to lower the cancer risk in number of 
investigations (Hsieh et al., 2015). Particularly peptides derived from milk have 
been well studied which will be brought up in this thesis. 
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4 Bioactive components in milk 
Bioactive components are referred to as specific constituents found in foods in 
small quantities and that beyond the nutritional function comprises beneficial 
physiological function. However, the term is somewhat extensive and could be 
interpreted differently. These components are being intensely studied because they 
may promote health and prevent diseases. All the studies of the different bioactive 
components that will be mentioned in this section are summarized in Table 1.  
     There is a large volume of published studies describing the role of bioactive 
components in milk. Many of them have been studied in milk from different spe-
cies. However, to date milk proteins are currently the foremost source of bioactive 
components and therefore the most well studied constituent in milk. Even though 
there is a large amount of studies related to other components in milk besides from 
milk proteins, no other constituents have been intensively studied and described as 
well like milk proteins. The majority of the bioactivity of the milk protein is 
dormant, incomplete or even absent in the original protein. However the liberation 
of the bioactivity could be achieved via proteolytic digestion to release the bioac-
tive peptide from the native protein (Park, 2009). There are different ways pep-
tides with biological activity can be produced. During food processing, such as 
milk fermentation using proteolytic starter cultures and in cheese maturation, bio-
active components are generated (Clare & Swaisgood, 2000). Bioactive compo-
nents could also be released during enzymatic hydrolysis through digestive en-
zymes in the gastrointestinal transportation. Digestive enzymes can naturally occur 
in milk and therefore supplement those products with bioactivity (Park, 2009). 
Lastly, bioactive peptides could be released by enzymes derived from microorgan-
isms or plants (Korhonen & Pihlanto, 2007). 
 
4.1 Calcium 
Calcium is an essential mineral and one of the most abundant mineral in the hu-
man body. It is a crucial nutrient required in numerous biological functions in the 
body such as skeletal mineralization. Therefore, the loss of calcium through nail, 
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skin, hair as well as urine and feces must be replaced from the daily diet. The cal-
cium requirement is however reliant on the state of the calcium metabolism which 
is individual (Peacock, 2010). Today the predominant source of calcium in the 
human diet is milk and dairy products. The majority of the calcium in milk is 
bound to casein, and to minor extent to other milk proteins, phosphorus and cit-
rate. There is also a small fraction of the calcium that exist in an unbound form 
(Park, 2009). During the past twenty years, research has proven that calcium in 
dairy products has a beneficial role and the level of consumption of milk and dairy 
product is correlated to many of the 21st century diseases (Ibeagha-Awemu  et al., 
2009).  
   A study made on adolescent girls showed that an increase in milk consumption 
augments the bone mineral acquisition and could change attainment of peak bone 
mass (Cadogan et al., 1997). It is also reported in a two year prospective analysis 
that higher intake of calcium is associated with reduced fat mass in young women 
(Lin et al., 2000). 
 
 
4.2 Conjugated linoleic acid (CLA) 
Conjugated linoleic acid (CLA) refers to a group of polyunsaturated fatty acids 
with 18 carbons and two conjugated double bonds (C18:2) in cis or trans position 
(Aro et al., 2000). The most biologically active isomers of CLA is reported to be 
cis-9, trans-11 which can be found in milk and dairy products. Cis-9, trans-11 
CLA is also referred to as rumenic acid. In milk fat, approximately 75-90 % of the 
total CLA is in the cis-9, trans-11 form (Collomb et al., 2006).  
 During the past years, numerous of animal trials have proven various health 
profits of CLA in milk (Dhiman et al., 1999). In rats, the isomer cis-9, trans-11 
CLA has been reported to have an anticarcinonegic effect (Corl et al., 2003). Fur-
thermore, studies in human have also proven a number of positive effects (Roche 
et al., 2001). A clinical study by Jiang et al. (1999) investigated the relation be-
tween the bovine milk fat and occurrence of positive effects in the human adipose 
tissue. The investigation showed that there was a significant correlation between 
intake of milk fat and the amount of CLA found in the serum of the participants. It 
was concluded in the study that the negative health aspects of milk fat should be 
re-evaluated since CLA have demonstrated to have positive health effect accord-
ing to various amount of literature. Moreover additional scientific data are re-
quired to complement the result of this study. 
 
4.3 Glycomacropeptide (GMP) 
GMP is a fragment of  the C-terminal f(106- 169) from κ-casein which is re-
leased by action of the protease chymosin (Keogh & Clifton, 2008). It is an hydro-
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philic peptide and has a molecular weight of roughly 8000 Daltons which makes it 
a rather small molecule (Park, 2009). GMP is released during cheese making upon 
adding rennet that contains the key component, chymosin. GMP remains in the 
whey fraction through this process and will not be included in the cheese curd 
(Brody, 2000).  
There have been several studies on GMP and its acquired bioactivity. Research 
has shown that GMP has antimicrobial activity in vitro by inhibiting production of 
several toxins produced by bacteria. Kawasaki et al. (1992) concluded that GMP 
from bovine milk inhibits cholera toxin from binding to its receptor. The study 
was made on Chinese hamster ovary (CHO)-Kl cells. Azuma et al. (1984) has 
shown that GMP from human milk promotes the growth of bifida bacteria and 
therefore suggested to be an important bifida factor. This study also reported that 
GMP from human milk had four times higher growth-promoting activity for 
bifidobacteria than GMP from bovine milk. In this case, GMP from bovine milk 
was used as a reference. The outcome of this is not clear, but the study suggests 
that when incubated with pepsin, GMP from human milk has the ability to be  
hydrolyzed by further steps. Furthermore, intact κ-casein showed growth-
promoting activity as well though the activity was enhanced when hydrolysis of 
either chymosin or pepsin was used to release GMP.  
 
4.4 Immunoglobulin 
Immunoglobulins (Ig) are antibodies present in the milk and colostrums of lac-
tacting mammals produced as a response to stimulation by specific antigens 
(Korhonen, 2009; Mehra et al., 2006). The biological function and also the main 
role of  Ig is to give the offspring protection from pathogens and infection. The 
young mammals are therefore depending on colostrum as a passive immune sys-
tem throughout the development of their own immune system (Mehra et al., 2006). 
Ig:s are divided into different classes depending on the structure, properties and 
biological function. The five main classes are IgA, IgD, IgE, IgG, and IgM 
(Chandan, 2007).   
 A randomized, double-blind, parallel-group, placebo controlled study reported 
that consumption of Ig from bovine milk emerged to have a positive effect on 
patients suffering from mild hypercholesterolemia. The result showed that both 
total cholesterol measured from baseline and LDL-cholesterol decreased (Earnest 
et al., 2005).  
 Over the past decades, a vast amount of studies have demonstrated that milk 
with Ig can be effective in avoidance of diseases due to pathogenic microbes. In a 
study by Tacket et al. (1992) it was demonstrated that an intake of oral bovine Ig 
concentrate derived from colostrum had a protective efficiency against the patho-
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gen Shigella. The study was performed on healthy young adults in a randomized, 
double blinded study. 
 
4.5 α - Lactalbumin 
α-La is a predominant protein in milk, mostly in human and bovine milk. The 
protein contains the amino acid cysteine, methionine and tryptophan in high quan-
tities. The sulfur amino acids give rise to the disulfides in the molecule. α-La has 
revealed to obtain a vital physiological role in biosynthesis of lactose in the mam-
mary gland where α-La is produced. Alongside the enzyme uridine-diphosphate 
galactosyl transferase,  α-La is a part of the lactose synthesis through catalyzing 
the conveyance of galactose to glucose to lastly form lactose (Chandan, 2007).  
 α-La has also revealed to be a metal-binding protein, specifically for calcium. 
This may further have an important biological function according to Hiraoka et al. 
(1980). Another study has suggested that the metal-binding property could be sig-
nificant for the lactose synthase complex and hence have a physiological meaning 
(Lönnerdal & Glazier, 1985). Animal studies have also been conducted to investi-
gate the bioactivity of α-La. A study by Matsumoto et al. (2001) reported that α-
La had an antiulcer function. The study investigated the effect of bovine α-La on 
gastric mucosal injury in rats. Before the gastric mucosal injury was induced by 
ethanol and stress, the test proteins were given orally. Matsumoto et al. (2001) 
concluded that α-La had an protective effect against gastric mucosal injury.  It has 
been known that milk is effective in preventing ulcers that had been induced for 
experimental reasons (Kivinen et al., 1992; Dial & Lichtenberger, 1987). Howev-
er, the study conducted by Matsumoto et al. (2001) is the first of its kind. Due to 
α-La being rich in the amino acid cysteine, tryptophan, and methionine, studies 
investigating if these amino acids have a function have been performed. One such 
study looked into if α-La derived from bovine milk could be involved in increas-
ing the brain tryptophan and serotonin activity. It is known that high serotonin 
activity may be related to the ability to cope with stress and mood. Serotonin is 
synthesized from the amino acid tryptophan. The brain serotonin concentration 
increases with intake of food with high tryptophan availability. For this reason, a 
diet with high concentration with tryptophan was given to the participants. α-La,  
with high concentration of tryptophan, was therefore used in this double-blind, 
placebo-controlled study. The study did indeed show that an enriched α-La diet 
significantly increased the plasma ratio of tryptophan to other large amino acid 
(Trp-LNAA ratio) (Markus et al., 2000).  
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4.6 Lactoferrin 
Lactoferrin (LF) is an iron-binding glycoprotein found in milk and in other exo-
crine secretion. The structure of LF consists of a single chain polypeptide with two 
globular lobes (Korhonen, 2009). Due to its iron-binding property, LF has shown 
to provide several physiological purposes in the biological system. The LF con-
centration differ significantly among the milk type as other bioactive components 
do (Lönnerdal & Iyer, 1995). 
 To date, several studies have investigated the antimicrobial activity of LF. 
Many of these studies have explored the correlation between the antimicrobial 
property of LF and its ability to bind iron. In a study by Ellison et.al (1998) it was 
demonstrated that LF from human milk increased the antibacterial effect by dam-
aging the outer membrane of gram-negative bacteria. A different study also inves-
tigated the correlation between LF and the iron-binding property and stated a simi-
lar conclusion (Masson et al., 1966). However this study was conducted several 
years prior Ellison et al. (1998) and only concluded that the antimicrobial feature 
could be due the iron-binding properties of LF (Masson et al., 1966). It has more-
over been reported that orally administered LF could be a potential natural anti-
bacterial agent. This particular study showed that LF had protective effects regard-
ing bacterial infection by Staphylococcus aureus (Bhimani et al., 1999). Bovine 
LF has also shown to have antimicrobial property against infection by Escherichia 
coli (Teraguchi et al., 1995)  and Heliobacter pylori (T. Wada, 1999).  
LF has furthermore revealed to have anticancer effect in animal studies. In a 
study by Sekine et al. (1997),  it was implied that bovine LF, which was orally 
administered, could operate as a chemopreventer for colon cancer in male rats.  
 
4.7 β - Lactoglobulin 
β-Lactoglobulin (β-Lg) is one of the main whey proteins in milk of some mam-
malian genera. It has been reported that β-Lg has four genetic variants, A, B, C 
and D. The protein contains a large amount of sulfur due to its cystein residues 
(Chandan, 2007). β-Lg has proven to have a wide range of bioactivities and nu-
merous studies have investigated the ACE-inhibitory activity and effect on blood 
cholesterol.   
A study investigating ovine and caprine whey reported ACE - inhibitory activity 
of β-Lg. It was observed that higher activity was obtained with peptides from β-Lg 
after action of microbial enzymes rather than digestive enzymes. Hernández-
Ledasma et al. (2002) suggested that the cleavage was more adequate for the crea-
tion of ACE - inhibitory peptides with enzymes from bacterial origin . Hernández-
Ledasma et al. (2002) also demonstrated potent ACE - inhibitory activity in vitro 
when β-Lg was administered orally in rats. Two peptides were evaluated and both 
indicated decrease in blood pressure after administration. However, when the pep-
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tide was subjected to a simulated gastrointestinal digestion in the same study there 
was no indication of ACE - inhibitory activity. Therefore, it may be crucial to 
validate and perform further studies. 
In a model study conducted by Nagaoka et al. (2001) peptide derivates from β-
Lg effectively influenced on serum cholesterol levels and also had a great hypo-
cholesterolemic activity.  
 
4.8 Oligosaccharides 
Other than lactose, oligosaccharides are also important carbohydrates in milk.  
These sugars make a substantial contribution to the carbohydrate content, in hu-
man milk for example up to 1.4 % of the entire carbohydrate content (Korhonen & 
Pihlanto, 2007). Oligosaccharides contain between 3 - 10 monosaccharide units 
that are linked through glycosidic bonds (Mehra & Kelly, 2006). Great deals of 
previous research on oligosaccharides are mostly focused on human milk since 
they are highly abundant in human milk. That the amount of oligosaccharides in 
milk from other animals is low compared to human milk is the reason for  lack of 
studies on milk from other species (Kunz & Rudloff, 2006). There is an increasing 
evidence that the principal role of oligosaccharides seems to be to administer the 
protection against pathogens (Kunz et al., 2000). By functioning as competitive 
inhibitors on the binding site of the intestinal epithelial surface may give physio-
logical protection (Gopal & Gill, 2000).   
 A study on oligosaccharides from goat milk in rats suggested that they play an 
important role in protecting the intestine and repair the damage of induced colitis 
(Lara-Villoslada et al., 2006). 
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Bioactive component 
 
Bioactivity and suggested health effect 
 
Study design 
 
Reference 
 
Calcium 
Reducing fat mass  Increased bonemass Prospective analysis  Open randomised intervention study Lin et al., 2000  Cadogan et al., 1997 
 
Conjugated linoleic acid (CLA) 
Anticancerogenic  Significant higher amount of CLA in blood serum 
Animal study 
 
Observational study 
Corl et al., 2003  Jiang et al., 1999 
 
 
Glycomacropeptide (GMP) 
Promotes growth of bifida bacteria (bifidus factor)  Inhibition of binding cholera toxin  
In vitro (using bifidobacterium infantis)   In vitro (using Chinese hamster ovary (CHO)-Kl cells) 
Azuma et al., 1984   Kawasaki et al., 1992  
 
Immunoglobulin 
Cholesterol-lowering effects   Protective efficiency against Shigella 
Randomized, double-blind, parallel-group, placebo-controlled study  In vitro 
Earnest et al., 2005   Tacket et al., 1992 
 
 
α  - Lactalbumin 
Protection against gastric mucosal injury   Calcium-binding  Increased the plasma ratio of tryptophan 
Animal study (Rats)  In vitro  
Double-blind, placebo-controlled study 
Matsumato et al., 2001  Hiraoka et al., 1980  Markus et al., 2000 
 
 
Lactoferrin 
Antimicrobial  Antimicrobial  Anticancer 
In vitro  Animal study (mice)  Animal study (rats) 
Ellison et al., 1988  Bhimani et al., 1999  Sekine et al., 1997 
 
 
 
β  - Lactoglobulin 
Influence serum cholesterol levels and exhibit a greater hypocholesterolemic activity  ACE - inhibitory activity  ACE - inhibitory activity  
Animal study (mice)   In vitro   Animal study 
Nagaoka et al., 2001   Hernández-Ledesma et al., 2002   Hernández-Ledesma et al., 2007 
 
Oligosaccharides 
Reduce intestinal inflammation (Antiinflammatory)  Animal study (Rat)  Lara-Villoslada et al., 2007 
Table 1. Bioactive components in milk and the resulting bioactivity as reported in various studies 
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5. Bioactive components in dairy products 
5.1 Cheese products 
     Making cheese has distinctive food processing procedures that make cheese 
unique. These processes include fermentation and ripening and it is also these 
processes that give rise to important bioactive components. Cheese products 
have been manufactured through a wide range of process techniques, to meet 
requirements that consumers are demanding. By using a diverse range of lactic 
acid bacteria as a starter culture, different tastes of cheese and specific health 
requirements can be made. All the studies on the cheese products that will be 
mentioned in this section below are summarized in Table 2. 
          Higurashi et al. (2007) studied the effect of Gouda-type cheese consumption 
on the accumulation of abdominal adipose. The experiment was performed on 
rats to examine the effects of Gouda-type cheese on some biological markers of 
the metabolic syndrome. It was discovered that the cheese fed rats had an ex-
tensively lower weight of the adipose tissues. These results were compared to 
rats fed with a diet comparable with respect to fat content but instead contained 
butterfat and casein. Furthermore, the cheese-fed rats revealed to have a de-
creased level of cholesterol in very low density lipoprotein as well of the level 
of serum in low density lipoproteins. Higurashi et al. (2007) suggests that 
cheese consumption has a suppressive effect on abdominal adipose accumula-
tion and may prevent the metabolic syndrome. 
         Up to now, a number of studies have showed that ripened cheese contains 
peptides with antihypertensive effects. Meisel et al. (1997) have reported ACE-
inhibitory peptides in ripened cheese. The ACE-inhibitory activity increased 
during cheese maturation. However, the ACE-inhibitory activity decreased 
when a certain level of proteolysis of the peptides was exceeded. Ryhänen et al. 
(2001) produced a new type of cheese with a mix of starter cultures from Lac-
tobacillus acidophilus and Bifidobacterium spp. The ''Festivo'' cheese was rip-
ened for 13 weeks and stored for 4 months before test was performed. The 
analysis detected that the ''Festivo'' cheese had ACE-inhibitory activity. Several 
peptides isolated from Italian cheese (Mozarella, Italico, Crescenza and Gor-
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gonzola) have reported to have inhibitory activity against proteolytic enzymes 
from lactic acid bacteria used as starter cultures. Moreover, most of these 
cheese peptides showed ACE-inhibitory activity (Smacchi & Gobbetti, 1998). 
Antihypertensive peptides have also been found naturally in gouda cheese 
(Saito et al., 2000).  
 
    5.2 Yoghurt and other fermented dairy products 
    Yoghurt can be referred to as fermented milk and is produced through lactic 
acid fermentation with the presence of Lactobacillus delbreuckii subsp. bulgar-
icus and Streptococcus thermophilus. Nonetheless, it is very common to add 
other lactic acid bacteria species to give the product characteristic features. Bo-
vine milk is the most common milk for producing yoghurt in the Western world 
however yoghurt from ovine, caprine and buffalo milk are used as well 
(Korhonen & Pihlanto, 2007).  The studies brought up in this section are sum-
marized in Table 2. Numerous studies have been published claiming that fer-
mented dairy products, including yoghurt, have beneficial health effects. For in-
stance, Donkor et al. (2007) in an in vitro study identified ACE-inhibitory pep-
tides in probiotic yoghurt. These peptides were most likely degraded from ca-
seins.  
    A placebo-controlled study by Hata et al. (1996) studied the effect of sour 
milk on elderly hypertensive patients. The sour milk contained starter culture 
from Lactobacillus helveticus and Saccharomyces cerevisiae. The patients in-
gested 95 mL of the sour milk for 8 weeks. It was found that both diastolic and 
systolic blood pressure of the hypertensive patients significantly decreased. Fur-
thermore, blood pressure remained decreased for 4 weeks after the study ended. 
It was suggested that these effects could be due to two types of tripeptides in 
the sour milk . The tripeptides were previously reported to be ACE-inhibitors in 
studies on rats (Nakamura et al., 1995).  
        In a population-based cohort study conducted by Larsson et al. (2005) the 
relation between high-fat dairy product (whole milk, full-fat cultured milk, 
cheese, cream, sour cream and butter) consumption and colorectal cancer was 
investigated. The participants were women aged 40-76 and were participants of 
the Swedish Mammography Cohort. The participant reported their daily food 
intake by answering questionnaires. Larsson et al. (2005) suggested that the 
prospective data indicated that a high consumption of dairy foods might lower 
the risk of colorectal cancer, and that this observation could be related to CLA 
intake. CLA is a bioactive component that has been shown to possess anti-
carcinogenic effects, however Larsson et al. (2005) point out that other poten-
tially anti-carcinogenic components cannot be excluded. 
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Dairy product 
 
Bioactivity and suggested health 
effect 
 
Study design 
 
Reference 
 Gouda cheese  Beneficial effect on abdominal adi-pose  Animal study (rats)  Higurashi et al., 2007  Cheese  ACE-inhibitory   -  Meisel et al., 1997  ''Festivo'' cheese      ACE-inhibitory  In vitro  Ryhänen et al., 2001 
 Italian cheese( Mozzarella, Italico, Crescenza, and Gorgonzola)                         ACE-inhibitory  In vitro  Smacchi & Gobetti, 1998  Yoghurt                          ACE-inhibitory  In vitro  Donkor et al., 2007 
 Sour milk  Reduce hypertension  Placebo controlled study  Hata et al., 1996 
High fat dairy products(whole-milk, full-fat cultured milk, cheese, cream, sour cream and butter)  Lower risk of colorectal cancer  Prospective cohort study  Larsson et al., 2005 
Table 2. Bioactive components in dairy products and the resulting bioactivity as reported in various studies 
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6. Discussion 
 
The occurrence of bioactive components in milk and dairy products is well docu-
mented and investigated. The research into the health benefits has expanded the 
past decades and the potential health benefits from the various components have 
gained commercial interest globally in the perspective of producing health promot-
ing functional foods (Park, 2009). Milk and dairy products are one of the few 
foods that have bioactive components present naturally and studies have reported 
various type of health benefits from their consumption. The studies summarized in 
Table 1 and 2 together with other extensive research have revealed milk and dairy 
products to be significant sources of bioactive components. However, the design 
and the model of the studies can affect the outcome. This need to be taken into 
consideration when stating health claims. There are several aspects to be taken in 
account when evaluating the bioactivity of the substances in milk and dairy prod-
ucts.  
       Milk proteins are the most studied constituents of milk. There are great 
amount of studies and evidence on stability, bioavailability, and impact on health 
that these components provide.  Not only do proteins contribute the nutritional 
value but also extensive research has proven that peptides originating from milk 
proteins possess health affect such as ACE-inhibitory activity. Many studies per-
formed in vitro have investigated peptide derivates from milk proteins by absorb-
ing the peptide in vivo and see the biological effect of the intact molecule. Howev-
er, there are restrictions in conducting human clinical investigations or epidemio-
logical studies designed to investigate the bioactivity of milk proteins and other 
components in milk and dairy products. Therefore, many existing studies are made 
in vitro which can more or less be used as an approximation and as an alternative 
to investigate the properties of milk components. Performing a study in vitro has 
its advantages and disadvantages. In vitro studies gives an insight into how the 
mechanism of an bioactive components can operate (Chatterton et al., 2004). Con-
sequently, there is lack of information available in terms of how it would function 
and affect the human health. To confirm beneficial health effects of bioactive 
components it is required to design human clinical trials or epidemiological studies 
based on information that could explore new biomarkers associated to the different 
observed health benefits (Hsieh et al., 2015). Further research is necessary, partic-
ularly in humans to completely understand the role of the bioactive components. 
The expansion of the functional food or foods with health properties beyond the 
generally accepted nutritional benefits is quickly evolving in the food industry and 
even beyond. The evolving research in this area will in the future be vital for de-
velopment of new functional foods, but also for understanding the diverse roles 
components in foods could have beyond the nutritional aspects. 
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